Laurence J.N. Cooper

• 
  www.eurekalert.org/pub_releases/2009-02/uotm-dat021309. - [Cached Version]
  Published on: 2/13/2009    Last Visited: 2/13/2009  

  IMAGE: This is Laurence Cooper, M.D., Ph.D., of the Children's Cancer Hospital at the University of Texas M. D. Anderson Cancer Center. Click here for more information.
  ...
  Choi, along with senior researcher Laurence Cooper, M.D., Ph.D., from the Children's Cancer Hospital, are studying ways to genetically manipulate T cells, an important component of a person's immune system, to specifically attack tumor cells while keeping risk to the patient at a minimum.
  ...
  "Our goal is to provide therapy to patients closer to their time of need," says Cooper. "The HitMeD processes a larger volume of T cells in a continuous fashion over a much shorter time than we can achieve with commercial devices. We hope that will translate to better treatment opportunities for relapsed patients."
  
  Cooper and researchers are planning a Phase I trial that could open this year.

• 
  www.mdanderson.org/departments/newsroom/display.cfm?id= - [Cached Version]
  Published on: 12/8/2008    Last Visited: 2/5/2009  

  Laurence Cooper, M.D., Ph.D., associate professor and head of the Cell Therapy Program at the Children's Cancer Hospital, has already initiated clinical trials using cell therapy to treat children with relapsed cancer. Currently, he is investigating how to standardize the production of cells infused with various genes. Once this is achieved, cell-based gene therapy, like Kleinerman's IL-12 gene therapy, can be used in clinical trials for patients.

• 
  www2.mdanderson.org/cancerwise/patient-care/cancer-trea - [Cached Version]
  Published on: 9/24/2009    Last Visited: 9/24/2009  

  By: Laurence Cooper, M.D., Ph.D., associate professor, Department of Pediatrics

• 
  www.mdanderson.org/departments/newsroom/display.cfm?id= - [Cached Version]
  Published on: 5/15/2008    Last Visited: 2/5/2009  

  Other investigators on the study include Shiguo Zhu, Ph.D, and Laurence Cooper, M.D., Ph.D. from the Children's Cancer Hospital at M. D. Anderson.

• 
  www.nfcr.org/Default.aspx?tabid=271 - [Cached Version]
  Published on: 3/20/2007    Last Visited: 3/20/2007  

  Laurence J.N. Cooper, M.D. Ph.D.
  ...
  Laurence J.N. Cooper, M.D. Ph.D. at City of Hope National Medical Center

• 
  www.honionline.com/honi/index.php?option=com_content&ta - [Cached Version]
  Last Visited: 12/12/2008  

  Laurence Cooper, M.D., Ph.D., associate professor and head of the Cell Therapy Program at the Children's Cancer Hospital, has already initiated clinical trials using cell therapy to treat children with relapsed cancer. Currently, he is investigating how to standardize the production of cells infused with various genes. Once this is achieved, cell-based gene therapy, like Kleinerman's IL-12 gene therapy, can be used in clinical trials for patients.

• 
  www4.nfcr.org/ResearchPrograms/NFCRProjectDirectors/tab - [Cached Version]
  Published on: 5/21/2009    Last Visited: 5/21/2009  

  Laurence J.N. Cooper, M.D., Ph.D.

• 
  www4.nfcr.org/ResearchPrograms/NFCRProjectDirectors/Lau - [Cached Version]
  Published on: 5/21/2009    Last Visited: 5/21/2009  

  Research Programs   »   NFCR Project Directors   »   Laurence J.N. Cooper, M.D., Ph.D.
  ...
  Laurence J.N. Cooper, M.D., Ph.D.
  ...
  Laurence J.N. Cooper, M.D., Ph.D.

• 
  www.nfcr.org/Default.aspx?tabid=350 - [Cached Version]
  Published on: 4/22/2006    Last Visited: 3/20/2007  

  Laurence J.N. Cooper, M.D. Ph.D.
  ...
  Home » NFCR Research Programs » NFCR Project Directors » Laurence J.N. Cooper, M.D. Ph.D.
  ...
  Laurence J.N. Cooper, M.D., Ph.D. City of Hope National Medical Center
  ...
  For more information on Dr. Cooper's research, please visit : http://www.cityofhope.org/cno/cooper.asp

• 
  www.alexslemonade.org/grants_2007.php - [Cached Version]
  Published on: 1/1/2007    Last Visited: 9/1/2008  

  Dr. Laurence Cooper

Page:  1 2 3 4 5